نتایج جستجو برای: dulaglutide
تعداد نتایج: 259 فیلتر نتایج به سال:
Journal:
:Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
2016
Journal:
:Pharmacy Today
2014
Journal:
:Journal of the American College of Cardiology
2021
Journal:
:Meditsinskiy sovet = Medical Council
2021
Journal:
:Endocrine Regulations
2019
Journal:
:Journal of the Endocrine Society
2020
2015
S. Christopher Jones
Debra L. Ryan
Valerie S.W. Pratt
Ali Niak
Allen D. Brinker
G lucagon-like peptide-1 (GLP-1) receptor agonists are safe and effective U.S. Food and Drug Administration (FDA)-approved drug products for use in the treatment of type 2 diabetes. To date, the FDA has approved five GLP-1 receptor agonist parenteral formulations: exenatide, liraglutide, exenatide extended-release , and, most recently, albiglutide and dulaglutide. All of these formulations are ...
Journal:
:Open Journal of Endocrine and Metabolic Diseases
2021
Journal:
:Journal of the Endocrine Society
2021
Journal:
:Value in Health
2016
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید